Advanced search
1 file | 568.96 KB Add to list

Médicaments et conduite automobile

(2015) PRESSE MEDICALE. 44(10). p.1055-1063
Author
Organization
Abstract
Some drugs are known to impair driving because they can change the vision or hearing, and/or disrupt the intellectual or motor abilities: impaired vigilance, sedation, disinhibition effect, the coordination of movement disorders and the balance. The doctor during prescribing and the pharmacist during deliverance of drug treatment should inform their patients of the potential risks of drugs on driving or operating machinery. The driver has direct responsibility, who hired him and him alone, to follow the medical advice received. The pictograms on the outer packaging of medicinal products intended to classify substances according to their risk driving: the driver can whether to observe simple precautions (level one "be prudent''), or follow the advice of a health professional (level two "be very careful''), or if it is totally not drive (level three "danger caution: do not drive''). This classification only evaluates the intrinsic danger of drugs but not the individual variability. Medicines should be taken into account also the conditions for which the medication is prescribed. It is important to inform the patient on several points: - not to change the prescribed dose due to the increase in adverse effects and therefore the risks for driving; - respect the hours and conditions of slots: at bedtime to hypnotics and no additional outlet when nocturnal awakening; - to avoid self-medication, alcohol and drugs particularly cannabis, whose dangerousness driving is demonstrated; - not to drive or stop driving when tired, sleepy, a feeling of heavy limbs, numb and trembling.
Keywords
PERFORMANCE, ANTIHISTAMINES, ALCOHOL, ANTIDEPRESSANTS, PRESCRIPTION, METAANALYSIS, DRIVERS, SAFETY, RISK

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 568.96 KB

Citation

Please use this url to cite or link to this publication:

MLA
Lemaire-Hurtel, Anne-Sophie et al. “Médicaments Et Conduite Automobile.” PRESSE MEDICALE 44.10 (2015): 1055–1063. Print.
APA
Lemaire-Hurtel, A.-S., Goullé, J.-P., Alvarez, J.-C., Mura, P., & Verstraete, A. (2015). Médicaments et conduite automobile. PRESSE MEDICALE, 44(10), 1055–1063.
Chicago author-date
Lemaire-Hurtel, Anne-Sophie, Jean-Pierre Goullé, Jean-Claude Alvarez, Patrick Mura, and Alain Verstraete. 2015. “Médicaments Et Conduite Automobile.” Presse Medicale 44 (10): 1055–1063.
Chicago author-date (all authors)
Lemaire-Hurtel, Anne-Sophie, Jean-Pierre Goullé, Jean-Claude Alvarez, Patrick Mura, and Alain Verstraete. 2015. “Médicaments Et Conduite Automobile.” Presse Medicale 44 (10): 1055–1063.
Vancouver
1.
Lemaire-Hurtel A-S, Goullé J-P, Alvarez J-C, Mura P, Verstraete A. Médicaments et conduite automobile. PRESSE MEDICALE. 2015;44(10):1055–63.
IEEE
[1]
A.-S. Lemaire-Hurtel, J.-P. Goullé, J.-C. Alvarez, P. Mura, and A. Verstraete, “Médicaments et conduite automobile,” PRESSE MEDICALE, vol. 44, no. 10, pp. 1055–1063, 2015.
@article{8026214,
  abstract     = {Some drugs are known to impair driving because they can change the vision or hearing, and/or disrupt the intellectual or motor abilities: impaired vigilance, sedation, disinhibition effect, the coordination of movement disorders and the balance. 
The doctor during prescribing and the pharmacist during deliverance of drug treatment should inform their patients of the potential risks of drugs on driving or operating machinery. 
The driver has direct responsibility, who hired him and him alone, to follow the medical advice received. 
The pictograms on the outer packaging of medicinal products intended to classify substances according to their risk driving: the driver can whether to observe simple precautions (level one "be prudent''), or follow the advice of a health professional (level two "be very careful''), or if it is totally not drive (level three "danger caution: do not drive''). 
This classification only evaluates the intrinsic danger of drugs but not the individual variability. Medicines should be taken into account also the conditions for which the medication is prescribed. It is important to inform the patient on several points: 
- not to change the prescribed dose due to the increase in adverse effects and therefore the risks for driving; 
- respect the hours and conditions of slots: at bedtime to hypnotics and no additional outlet when nocturnal awakening; 
- to avoid self-medication, alcohol and drugs particularly cannabis, whose dangerousness driving is demonstrated; 
- not to drive or stop driving when tired, sleepy, a feeling of heavy limbs, numb and trembling.},
  author       = {Lemaire-Hurtel, Anne-Sophie and Goullé, Jean-Pierre and Alvarez, Jean-Claude and Mura, Patrick and Verstraete, Alain},
  issn         = {0755-4982},
  journal      = {PRESSE MEDICALE},
  keywords     = {PERFORMANCE,ANTIHISTAMINES,ALCOHOL,ANTIDEPRESSANTS,PRESCRIPTION,METAANALYSIS,DRIVERS,SAFETY,RISK},
  language     = {fre},
  number       = {10},
  pages        = {1055--1063},
  title        = {Médicaments et conduite automobile},
  url          = {http://dx.doi.org/10.1016/j.lpm.2015.03.007},
  volume       = {44},
  year         = {2015},
}

Altmetric
View in Altmetric
Web of Science
Times cited: